Lisata Therapeutics to Announce Q2 2024 Financials and Business Update on August 12, 2024

Lisata Therapeutics, Inc. (Nasdaq: LSTA), a clinical-stage pharmaceutical company, has announced that it will release its financial results for the second quarter, which ended on June 30, 2024, on Monday, August 12, 2024, after trading hours. Along with the financial report, Lisata will hold a conference call at 4:30 p.m. Eastern time to discuss the results. Interested parties must register for the call through a provided link, after which registered participants will receive an email with the conference call details and dial-in options. It's recommended that participants dial in 15 minutes before the scheduled start to avoid any delays. Additionally, a live webcast of the conference call will be available on Lisata’s website under the Investors & News section. The webcast will be accessible for replay two hours after the call's conclusion and will remain available for 12 months.

Lisata Therapeutics is devoted to the discovery, development, and commercialization of innovative therapies aimed at treating advanced solid tumors and other serious diseases. The company’s leading product candidate, certepetide (formerly LSTA1), is an investigational drug that aims to activate a novel uptake pathway. This pathway is designed to help co-administered or tethered anti-cancer drugs more effectively target and penetrate solid tumors. 

Lisata’s research and development efforts are significantly bolstered by its CendR Platform® technology, which has already led to the establishment of substantial commercial and R&D partnerships. The company is anticipating the announcement of several key milestones over the next two years. Based on its current projections, Lisata expects its capital to fund operations into early 2026, which will cover anticipated data milestones from ongoing and planned clinical trials.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!